Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis

CONCLUSIONS: PSM analysis revealed NCHT before RP in OMPC patients has potential therapeutic benefits with acceptable toxicities and lower incidence of postoperative positive surgical margins.PMID:33824096 | DOI:10.1016/j.clgc.2021.02.004

Source: Clinical Prostate Cancer - April 7, 2021 Category: Cancer & Oncology Authors: Chenfei Chi Liancheng Fan Baijun Dong Yinjie Zhu Zhixiang Xin Jiahua Pan Wei Xue Source Type: research